HomeAI · summaries
Storia in 3 fonti
Abridge picks up strategic investment from Eli Lilly, expands payer, research workflows
Since launching eight years ago with an ambient medical transcription tool, Abridge has set is sights more broadly on building out a full-scale AI clinical assistant. | Abridge secured a strategic investment from Eli Lilly and unveiled a major platform expansion to integrate payer and life sciences workflows. Described as an "AI-native clinician intelligence platform," Abridge says it now connects care delivery, payment and evidence-based treatment.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercehealthcare.com
Abridge picks up strategic investment from Eli Lilly, expands payer, research workflows
Since launching eight years ago with an ambient medical transcription tool, Abridge has set is sights more broadly on building out a full-scale AI clinical assistant. | Abridge…
- ·
statnews.com
Abridge inks deals with Nvidia and Lilly
Abridge announced new deals with Eli Lilly and Nvidia as it aims to gain an edge in a competitive market.
- ·
fortune.com
Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it | Fortune
The $5.3 billion ambient AI startup is expanding from clinical notes into billing, drug trials, and real-time insurance claims.
- ·
Build vs. buy: the AI navigation decision you can't get wrong
Download this free guide today to explore how health payers can safely scale AI-driven healthcare solutions without increasing risk, covering care navigation use cases,…